Návratnost aktiv společnosti Illumina
Jaká je hodnota metriky Návratnost aktiv společnosti Illumina?
Hodnota metriky Návratnost aktiv společnosti Illumina, Inc. je -29.04%
Jaká je definice metriky Návratnost aktiv?
Návratnost aktiv (Return on assets - ROA) je rentabilita aktiv. Vypočítá se vydělením celkového příjmu průměrem celkových aktiv.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Návratnost aktiv společností v sektoru Miscellaneous sektor na LSE ve srovnání se společností Illumina
Čemu se věnuje společnost Illumina?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Firmy s metrikou návratnost aktiv podobnou společnosti Illumina
- Hodnota metriky Návratnost aktiv společnosti CST je -29.18%
- Hodnota metriky Návratnost aktiv společnosti Nanobiotix S.A je -29.16%
- Hodnota metriky Návratnost aktiv společnosti Nanobiotix SA je -29.16%
- Hodnota metriky Návratnost aktiv společnosti Planet Ventures je -29.14%
- Hodnota metriky Návratnost aktiv společnosti Gamesquare Esports je -29.13%
- Hodnota metriky Návratnost aktiv společnosti Calliditas Therapeutics AB (publ) je -29.11%
- Hodnota metriky Návratnost aktiv společnosti Illumina je -29.04%
- Hodnota metriky Návratnost aktiv společnosti BuildingIQ je -29.03%
- Hodnota metriky Návratnost aktiv společnosti Calamp je -29.01%
- Hodnota metriky Návratnost aktiv společnosti Field Trip Health je -29.01%
- Hodnota metriky Návratnost aktiv společnosti ADC Therapeutics SA je -29.00%
- Hodnota metriky Návratnost aktiv společnosti CBLT je -29.00%
- Hodnota metriky Návratnost aktiv společnosti iMetal Resources je -28.99%